News

Full US Food and Drug Administration approval of the Pfizer/BioNTech COVID-19 vaccine is "imminent," a senior federal official told CNN on Friday -- but said no date has been mentioned. A person ...
WASHINGTON (AP) — U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate access for millions of American adults and children.
Moderna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its COVID-19 vaccine for people age 18 and older, and Pfizer and BioNTech ...
The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for a new monovalent COVID-19 vaccine, COMIRNATY LP.8.1.
The Food and Drug Administration approved the 2025 COVID-19 vaccines, but only for those over age 65 or with chronic conditions.
The U.S. Food and Drug Administration cleared updated COVID-19 vaccines for everyone over age 65 but narrowed its approval ...
The Food and Drug Administration (FDA) had rescinded emergency use authorizations (EUAs) for COVID-19 vaccines, Health and ...
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
Pfizer Inc. (NYSE:PFE) is one of the top most undervalued low volatility stocks to buy now. Pfizer Inc. (NYSE:PFE) announced ...
WASHINGTON -- Moderna is applying for full government approval for its COVID-19 vaccine. The company said it is submitting trial data to the Food and Drug Administration on a rolling basis over the ...
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
NEW YORK (WABC) -- The U.S. Food and Drug administration says it is fast-tracking the process of issuing final and full approval for Pfizer's COVID-19 vaccine. An FDA spokeswoman says the agency is ...